September 25- QIAGEN N.V. (NASDAQ: QGEN) announces that it will issue 27.5 million newly issued common shares (the “Shares”) in

Acorda Therapeutics (Nasdaq: ACOR) announced today the initial public offering of 5,500,000 shares of common stock at a price of $6.00 per share. All of the shares are being offered by Acorda Therapeutics. Acorda’s common stock will begin trading today on The NASDAQ National Market under the symbol “ACOR.”